Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

UAS LifeSciences: Study Confirms Benefits of Probiotics and Cranberry Combination for Urinary Tract Health
  • USA - English


News provided by

UAS LifeSciences

Aug 03, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX


The results of the study are very promising and confirm the synergy of the active ingredients. We are looking forward to moving on to human trials.

Post this

Wausau, WI (PRWEB) August 03, 2016 -- It’s a problem known all too well by many women. That awful feeling of realizing you are having urinary tract issues. In fact, one in five women will experience urinary tract issues during their lifetime, and the bacteria that causes them is 10 times more common in women than men. Now, the results of an in vitro (conducted outside of a living organism) clinical trial, published in the August 2016 edition of the Journal of Functional Foods, may be able to provide some relief as well as answers. Results of the study indicated that the combination of whole organic cranberry powder and specific probiotic strains may actually aid in supporting urinary tract health.

The study was conducted by UAS LifeSciences, manufacturer of UP4 Probiotics, and Fruit d'Or Nutraceuticals, manufacturer of Cran Naturelle. It was performed with the collaboration of Complete Phytochemical Solutions and the Reed Research Group at the University of Wisconsin-Madison, both well-known for their knowledge of plant bioactives.

“We are honored to have partnered with those at UW-Madison that specifically have expertise with cranberry proanthocyanidins (PACs), the active ingredient in cranberries for supporting urinary tract health,” states Dr. Greg Leyer, Chief Scientific Officer of UAS LifeSciences as well as one of the study’s authors. He adds, “The results of the study are very promising and confirm the synergy of the active ingredients. We are looking forward to moving on to human trials.”

The product studied was UP4 Women’s, a part of UAS LifeSciences’s line of award-winning probiotic supplements. It contains a mix of robust, acid and bile resistant probiotic strains found naturally in a healthy vaginal cavity (including their trademarked superstrain Lactobacillus acidophilus DDS-1) in addition to whole organic Cran Naturelle cranberry powder.

“Cran Naturelle was selected as the cranberry powder used in this formulation because of its superior quality. There is no other cranberry powder available with a higher concentration of PACs,” states Stephen Lukawski, Director of Sales and Business Development for Fruit d'Or, manufacturer of Cran Naturelle.

Based on this positive outcome, gold standard, double-blind, placebo-controlled human trials are planned.

You can find UP4 Probiotics at Target stores nationwide along with fine health food stores including The Vitamin Shoppe, Whole Foods, and Sprouts Farmers Market.

The complete study can be viewed on the Journal of Functional Foods website:

http://www.sciencedirect.com/science/article/pii/S1756464616301359

Polewski, MA, Krueger, CG, Reed, JD, and G. Leyer. 2016. Ability of cranberry proanthocyanidins in combination with a probiotic formulation to inhibit in vitro invasion of gut epithelial cells by extra-intestinal pathogenic E. coli. J. Functional Foods. 25: 123-134.

About UAS LifeSciences
Founded in 1979, UAS LifeSciences, has delivered the highest quality, science-backed probiotics to the wellness products marketplace for more than thirty-five years. Strictly dedicated to probiotic-based supplements, UAS LifeSciences is committed to designing innovative and effective formulations including Lactobacillus acidophilus DDS®-1, one of the few probiotic strains researched to be beneficial in all age groups, and the patented Lactobacillus reuteri NCIMB 30242 (LRC™), the first strain clinically studied for supporting healthy cholesterol levels. The company is fully integrated from formulation through manufacturing, from packaging through marketing and distribution and adheres to the highest quality standards. To learn more, visit up4probiotics.com.

About Fruit d'Or
Fruit d'Or Nutraceuticals is a global leader in organic processing and supply of nutraceutical cranberry and blueberry powders. The company positions itself as a next generation partner in advanced cranberry by providing cutting-edge innovation in technology and science. Fruit d'Or Nutraceuticals engages in product development, research and a commitment to quality and safety to distinguish itself from the competition. The company controls the quality from the seed to the field, from harvest to manufacturing to retail. This one-stop Canadian facility provides non-GMO, organic, state-of-the-art quality control, and traceability, key factors to its and the industry's future growth and long-term success. Explore http://www.crannaturelle.ca.    

References
2014. Urinary tract infection in women. http://umm.edu/health/medical/altmed/condition/urinary-tract-infection-in-women.
2010. Urinary Tract Infections. https://www.kidney.org/sites/default/files/uti.pdf.

Mariah Saerndahl, UAS LifeSciences, http://up4probiotics.com/, +1 (608) 729-0690, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.